These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The use of adalimumab in severe fistulising Crohn's disease].
    Author: Bang UC, Nielsen AM.
    Journal: Ugeskr Laeger; 2008 Jun 16; 170(25):2256. PubMed ID: 18565318.
    Abstract:
    So far infliximab is the only approved anti-TNF-alpha antibody for patients with Crohn's disease. Development of antibodies to infliximab may result in allergic reactions or reduced effect. We report three patients who received adalimumab, which induced longstanding remission in all three patients.
    [Abstract] [Full Text] [Related] [New Search]